{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:39:42Z","timestamp":1790739582791,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2001,9,1]],"date-time":"2001-09-01T00:00:00Z","timestamp":999302400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Allergy Asthma Rep"],"published-print":{"date-parts":[[2001,9]]},"DOI":"10.1007\/s11882-001-0030-6","type":"journal-article","created":{"date-parts":[[2007,6,2]],"date-time":"2007-06-02T16:23:51Z","timestamp":1180801431000},"page":"445-450","source":"Crossref","is-referenced-by-count":22,"title":["The hyper IgM syndrome"],"prefix":"10.1007","volume":"1","author":[{"given":"Ramsay L.","family":"Fuleihan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"30_CR1","first-page":"321","volume":"35","author":"RL Fuleihan","year":"1998","unstructured":"Fuleihan RL: The X-Linked Hyperimmunoglobulin M syndrome. Semin Hematol 1998, 35:321\u2013331.","journal-title":"Semin Hematol"},{"key":"30_CR2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0022-3476(97)70123-9","volume":"131","author":"J Levy","year":"1997","unstructured":"Levy J, Espanol-Boern T, Thomas C, et al.: Clinical spectrum of X-linked hyper-IgM syndrome. J Pediatr 1997, 131:47\u201354.","journal-title":"J Pediatr"},{"key":"30_CR3","doi-asserted-by":"crossref","first-page":"977","DOI":"10.4049\/jimmunol.158.2.977","volume":"158","author":"AR Hayward","year":"1997","unstructured":"Hayward AR, Levy J, Facchetti F, et al.: Cholangiopathy and tumors of the pancreas, liver, and biliary tree in boys with X-linked immunodeficiency with hyper-IgM. J Immunol 1997, 158:977\u2013983.","journal-title":"J Immunol"},{"key":"30_CR4","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1006\/smim.1998.0145","volume":"10","author":"LA Vogel","year":"1998","unstructured":"Vogel LA, Noelle RJ: CD40 and its crucial role as a member of the TNFR family. Semin Immunol 1998, 10:435\u2013442.","journal-title":"Semin Immunol"},{"key":"30_CR5","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1172\/JCI117476","volume":"94","author":"ME Conley","year":"1994","unstructured":"Conley ME, Larche M, Bonagura VR, et al.: Hyper IgM syndrome associated with defective CD40-mediated B cell activation. J Clin Invest 1994, 94:1404\u20131409.","journal-title":"J Clin Invest"},{"key":"30_CR6","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.4049\/jimmunol.158.6.2576","volume":"158","author":"A Durandy","year":"1997","unstructured":"Durandy A, Hivroz C, Mazerolles F, et al.: Abnormal CD40-mediated activation pathway in B lymphocytes from patients with hyper-IgM syndrome and normal CD40 ligand expression. J Immunol 1997, 158:2576\u20132584.","journal-title":"J Immunol"},{"key":"30_CR7","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0092-8674(00)00079-9","volume":"102","author":"P Revy","year":"2000","unstructured":"Revy P, Muto T, Levy Y, et al.: Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell 2000, 102:565\u2013575. This article demonstrates that mutations in AID cause autosomal recessive HIM.","journal-title":"Cell"},{"key":"30_CR8","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1006\/clim.2000.4956","volume":"97","author":"Y Minegishi","year":"2000","unstructured":"Minegishi Y, Lavoie A, Cunningham-Rundles C, et al.: Mutations in activation-induced cytidine deaminase in patients with hyper IgM syndrome. Clin Immunol 2000, 97:203\u2013210. This article shows that other gene defects may also cause autosomal recessive HIM because some of the study patients had no mutations in AID.","journal-title":"Clin Immunol"},{"key":"30_CR9","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/1074-7613(94)90095-7","volume":"1","author":"T Kawabe","year":"1994","unstructured":"Kawabe T, Naka T, Yoshida K, et al.: The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity 1994, 1:167\u2013178.","journal-title":"Immunity"},{"key":"30_CR10","doi-asserted-by":"crossref","first-page":"12135","DOI":"10.1073\/pnas.91.25.12135","volume":"91","author":"E Castigli","year":"1994","unstructured":"Castigli E, Alt F, Davidson L, et al.: CD40 deficient mice generated by RAG-2 deficient blastocyst complementation. Proc Natl Acad Sci U S A 1994, 91:12135\u201312139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"30_CR11","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/1074-7613(94)90073-6","volume":"1","author":"J Xu","year":"1994","unstructured":"Xu J, Foy TM, Laman JD, et al.: Mice deficient for the CD40 ligand. Immunity 1994, 1:423\u2013431.","journal-title":"Immunity"},{"key":"30_CR12","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1084\/jem.180.5.1889","volume":"180","author":"BR Renshaw","year":"1994","unstructured":"Renshaw BR, Fanslow WCr, Armitage RJ, et al.: Humoral immune responses in CD40 ligand-deficient mice. J Exp Med 1994, 180:1889\u20131900.","journal-title":"J Exp Med"},{"key":"30_CR13","first-page":"101","volume":"3","author":"LD Notarangelo","year":"1992","unstructured":"Notarangelo LD, Duse M, Ugazio AG: Immunodeficiency with hyper-IgM (HIM). Immunodefic Rev 1992, 3:101\u2013121.","journal-title":"Immunodefic Rev"},{"key":"30_CR14","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1073\/pnas.91.6.2110","volume":"91","author":"A Villa","year":"1994","unstructured":"Villa A, Notarangelo LD, Di Santo JP, et al.: Organization of the human CD40L gene: implications for molecular defects in X chromosome-linked hyper-IgM syndrome and prenatal diagnosis. Proc Natl Acad Sci U S A 1994, 91:2110\u20132114.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"30_CR15","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1002\/eji.1830221226","volume":"22","author":"D Graf","year":"1992","unstructured":"Graf D, Korthauer U, Mages HW, et al.: Cloning of TRAP, a ligand for CD40 on human T cells. Eur J Immunol 1992, 22:3191\u20133194.","journal-title":"Eur J Immunol"},{"key":"30_CR16","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/intimm\/5.7.769","volume":"5","author":"N Ramesh","year":"1993","unstructured":"Ramesh N, Fuleihan R, Ramesh V, et al.: Deletions in the ligand for CD40 in X-linked immunoglobulin deficiency with normal or elevated IgM (HIGMX-1). Int Immunol 1993, 5:769\u2013773.","journal-title":"Int Immunol"},{"key":"30_CR17","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/361539a0","volume":"361","author":"U Korthauer","year":"1993","unstructured":"Korthauer U, Graf D, Mages HW, et al.: Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature 1993, 361:539\u2013541.","journal-title":"Nature"},{"key":"30_CR18","first-page":"S474","volume":"99","author":"K Seyama","year":"1997","unstructured":"Seyama K, Nonoyama S, Hollenbaugh D, et al.: X-linked hyper IgM syndrome (XHIM) mutation analysis, CD40L function and clinical phenotype [abstract]. J Allergy Clin Immunol 1997, 99:S474.","journal-title":"J Allergy Clin Immunol"},{"key":"30_CR19","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1172\/JCI117377","volume":"94","author":"D Hollenbaugh","year":"1994","unstructured":"Hollenbaugh D, Wu LH, Ochs HD, et al.: The random inactivation of the X chromosome carrying the defective gene responsible for X-linked hyper IgM syndrome (X-HIM) in female carriers of HIGM1. J Clin Invest 1994, 94:616\u2013622.","journal-title":"J Clin Invest"},{"key":"30_CR20","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.4049\/jimmunol.153.7.3295","volume":"153","author":"RE Callard","year":"1994","unstructured":"Callard RE, Smith SH, Herbert J, et al.: CD40 ligand (CD40L) expression and B cell function in agammaglobulinemia with normal or elevated levels of IgM (HIM): comparison of X-linked, autosomal recessive, and non-X-linked forms of the disease, and obligate carriers. J Immunol 1994, 153:3295\u20133306.","journal-title":"J Immunol"},{"key":"30_CR21","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/(SICI)1521-4141(199901)29:01<367::AID-IMMU367>3.0.CO;2-4","volume":"29","author":"G Saint Basile de","year":"1999","unstructured":"deSaint Basile G, Tabone MD, Durandy A, et al.: CD40 ligand expression deficiency in a female carrier of the X-linked hyper-IgM syndrome as a result of X chromosome lyonization. Eur J Immunol 1999, 29:367\u2013373.","journal-title":"Eur J Immunol"},{"key":"30_CR22","doi-asserted-by":"crossref","first-page":"3648","DOI":"10.1002\/(SICI)1521-4141(199811)28:11<3648::AID-IMMU3648>3.0.CO;2-U","volume":"28","author":"P Revy","year":"1998","unstructured":"Revy P, Geissmann F, Debre M, et al.: Normal CD40-mediated activation of monocytes and dendritic cells from patients with hyper-IgM syndrome due to a CD40 pathway defect in B cells. Eur J Immunol 1998, 28:3648\u20133654. This article demonstrates that, although CD40 signaling is defective in B cells from patients with autosomal recessive HIM, it is normal in their monocytes and dendritic cells.","journal-title":"Eur J Immunol"},{"key":"30_CR23","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0092-8674(00)00078-7","volume":"102","author":"M Muramatsu","year":"2000","unstructured":"Muramatsu M, Kinoshita K, Fagarasan S, et al.: Class switch recombination and hypermutation require activationinduced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 2000, 102:553\u2013563. This article demonstrates the requirement for AID in immunoglobulin isotype switching and somatic hypermutation in B cells.","journal-title":"Cell"},{"key":"30_CR24","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0167-5699(96)80904-2","volume":"17","author":"LD Notarangelo","year":"1996","unstructured":"Notarangelo LD, Peitsch MC: CD40lbase: a database of CD40L gene mutations causing X-linked hyper-IgM syndrome. Immunol Today 1996, 17:511\u2013516.","journal-title":"Immunol Today"},{"key":"30_CR25","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1084\/jem.178.3.1097","volume":"178","author":"S Nonoyama","year":"1993","unstructured":"Nonoyama S, Hollenbaugh D, Aruffo A, et al.: B cell activation via CD40 is required for specific antibody production by antigen-stimulated human B cells. J Exp Med 1993, 178:1097\u20131102.","journal-title":"J Exp Med"},{"key":"30_CR26","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0022-3476(97)70139-2","volume":"131","author":"R Ameratunga","year":"1997","unstructured":"Ameratunga R, Lederman HM, Sullivan KE, et al.: Defective antigen-induced lymphocyte proliferation in the X-linked hyper-IgM syndrome. J Pediatr 1997, 131:147\u2013150.","journal-title":"J Pediatr"},{"key":"30_CR27","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1046\/j.1365-2249.2000.01235.x","volume":"120","author":"DP Inwald","year":"2000","unstructured":"Inwald DP, Peters MJ, Walshe D, et al.: Absence of platelet CD40L identifies patients with X-linked hyper IgM syndrome. Clin Exp Immunol 2000, 120:499\u2013502.","journal-title":"Clin Exp Immunol"},{"key":"30_CR28","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1073\/pnas.91.3.1099","volume":"91","author":"M Farrington","year":"1994","unstructured":"Farrington M, Grosmaire LS, Nonoyama S, et al.: CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency. Proc Natl Acad Sci U S A 1994, 91:1099\u20131103.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"30_CR29","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1006\/clim.1999.4799","volume":"93","author":"ME Conley","year":"1999","unstructured":"Conley ME, Notarangelo LD, Etzioni A: Diagnostic criteria for primary immunodeficiencies: representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol 1999, 93:190\u2013197. This article provides criteria for the diagnosis of several primary immune deficiency diseases.","journal-title":"Clin Immunol"},{"key":"30_CR30","doi-asserted-by":"crossref","first-page":"6624","DOI":"10.4049\/jimmunol.154.12.6624","volume":"154","author":"F Facchetti","year":"1995","unstructured":"Facchetti F, Appiani C, Salvi L, et al.: Immunohistologic analysis of ineffective CD40-CD40 ligand interaction in lymphoid tissues from patients with X-linked immunodeficiency with hyper-IgM: abortive germinal center cell reaction and severe depletion of follicular dendritic cells. J Immunol 1995, 154:6624\u20136633.","journal-title":"J Immunol"},{"key":"30_CR31","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1126\/science.7679801","volume":"259","author":"RC Allen","year":"1993","unstructured":"Allen RC, Armitage RJ, Conley ME, et al.: CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science 1993, 259:990\u2013993.","journal-title":"Science"},{"key":"30_CR32","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1126\/science.7537388","volume":"268","author":"C Arpin","year":"1995","unstructured":"Arpin C, D\u00e9chanet J, Van Kooten C, et al.: Generation of memory B cells and plasma cells in vitro. Science 1995, 268:720\u2013722.","journal-title":"Science"},{"key":"30_CR33","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1172\/JCI5891","volume":"103","author":"A Jain","year":"1999","unstructured":"Jain A, Atkinson TP, Lipsky PE, et al.: Defects of T-cell effector function and post-thymic maturation in X-linked hyper-IgM syndrome. J Clin Invest 1999, 103:1151\u20131158.","journal-title":"J Clin Invest"},{"key":"30_CR34","doi-asserted-by":"crossref","first-page":"6690","DOI":"10.4049\/jimmunol.162.11.6690","volume":"162","author":"CS Subauste","year":"1999","unstructured":"Subauste CS, Wessendarp M, Sorensen RU, Leiva LE: CD40-CD40 ligand interaction is central to cell-mediated immunity against Toxoplasma gondii: patients with hyper IgM syndrome have a defective type 1 immune response that can be restored by soluble CD40 ligand trimer. J Immunol 1999, 162:6690\u20136700. This article demonstrates defective TH1 cell-mediated immunity to a pathogen, Toxoplasma gondii, in patients with X-HIM and correction of the defect in vitro by soluble CD40 ligand.","journal-title":"J Immunol"},{"key":"30_CR35","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1600-065X.1996.tb00921.x","volume":"153","author":"IS Grewal","year":"1996","unstructured":"Grewal IS, Flavell RA: The role of CD40 ligand in costimulation and T-cell activation. Immunol Rev 1996, 153:85\u2013106.","journal-title":"Immunol Rev"},{"key":"30_CR36","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/jlb.63.4.418","volume":"63","author":"MF Mackey","year":"1998","unstructured":"Mackey MF, Barth RJ Jr, Noelle RJ: The role of CD40\/CD154 interactions in the priming, differentiation, and effector function of helper and cytotoxic T cells. J Leukoc Biol 1998, 63:418\u2013428.","journal-title":"J Leukoc Biol"},{"key":"30_CR37","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/eji.1830250442","volume":"25","author":"U Shu","year":"1995","unstructured":"Shu U, Kiniwa M, Wu CY, et al.: Activated T cells induce interleukin-12 production by monocytes via CD40-CD40 ligand interaction. Eur J Immunol 1995, 25:1125\u20131128.","journal-title":"Eur J Immunol"},{"key":"30_CR38","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.4049\/jimmunol.155.7.3525","volume":"155","author":"JA Wiley","year":"1995","unstructured":"Wiley JA, Harmsen AG: CD40 ligand is required for resolution of Pneumocystis carinii pneumonia in mice. J Immunol 1995, 155:3525\u20133529.","journal-title":"J Immunol"},{"key":"30_CR39","doi-asserted-by":"crossref","first-page":"263","DOI":"10.4049\/jimmunol.156.1.263","volume":"156","author":"JF Urban Jr","year":"1996","unstructured":"Urban JF Jr, Fayer R, Chen SJ, et al.: IL-12 protects immunocompetent and immunodeficient neonatal mice against infection with Cryptosporidium parvum. J Immunol 1996, 156:263\u2013268.","journal-title":"J Immunol"},{"key":"30_CR40","first-page":"160","volume":"16","author":"WC Wang","year":"1994","unstructured":"Wang WC, Cordoba J, Infante AJ, Conley ME: Successful treatment of neutropenia in the hyper-immunoglobulin M syndrome with granulocyte colony-stimulating factor. Am J Pediatr Hematol Oncol 1994, 16:160\u2013163.","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"30_CR41","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1056\/NEJM199508173330705","volume":"333","author":"C Thomas","year":"1995","unstructured":"Thomas C, de Saint Basile G, Le Deist F, et al.: Brief report: correction of X-linked hyper-IgM syndrome by allogeneic bone marrow transplantation. N Engl J Med 1995, 333:426\u2013429.","journal-title":"N Engl J Med"},{"key":"30_CR42","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/sj.bmt.1701512","volume":"22","author":"PR Scholl","year":"1998","unstructured":"Scholl PR, O\u2019Gorman MR, Pachman LM, et al.: Correction of neutropenia and hypogammaglobulinemia in X-linked hyper-IgM syndrome by allogeneic bone marrow transplantation. Bone Marrow Transplant 1998, 22:1215\u20131218.","journal-title":"Bone Marrow Transplant"},{"key":"30_CR43","first-page":"S101","volume":"101","author":"U Ziegner","year":"1998","unstructured":"Ziegner U, Dovat S, Wakim M, et al.: Partially mismatched cord blood transplants in X-linked immunodeficiencies [abstract]. J Allergy Clin Immunol 1998, 101:S101.","journal-title":"J Allergy Clin Immunol"},{"key":"30_CR44","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1056\/NEJM200002033420504","volume":"342","author":"N Hadzic","year":"2000","unstructured":"Hadzic N, Pagliuca A, Rela M, et al.: Correction of the hyper-IgM syndrome after liver and bone marrow transplantation. N Engl J Med 2000, 342:320\u2013324. This article demonstrates that liver failure and immune deficiency in X-HIM can be corrected by liver and bone marrow transplantation.","journal-title":"N Engl J Med"},{"key":"30_CR45","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1056\/NEJM199404073301404","volume":"330","author":"JP DiSanto","year":"1994","unstructured":"DiSanto JP, Markiewicz S, Gauchat JF, et al.: Brief report: prenatal diagnosis of X-linked hyper-IgM syndrome. N Engl J Med 1994, 330:969\u2013973.","journal-title":"N Engl J Med"},{"key":"30_CR46","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1126\/science.288.5466.669","volume":"288","author":"M Cavazzana-Calvo","year":"2000","unstructured":"Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, et al.: Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 2000, 288:669\u2013672. This article demonstrates that gene therapy can correct immune deficiency disease, namely X-linked severe combined immunodeficiency.","journal-title":"Science"},{"key":"30_CR47","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/3233","volume":"4","author":"MP Brown","year":"1998","unstructured":"Brown MP, Topham DJ, Sangster MY, et al.: Thymic lymphoproliferative disease after successful correction of CD40 ligand deficiency by gene transfer in mice. Nat Med 1998, 4:1253\u20131260. This article demonstrates that gene transfer of regulated expression of CD40 ligand will be required for gene therapy of X-HIM because transfer of constitutive CD40 ligand expression in CD40 ligand-deficient mice resulted in thymic lymphoproliferative disease.","journal-title":"Nat Med"},{"key":"30_CR48","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1002\/art.1780401002","volume":"40","author":"SK Datta","year":"1997","unstructured":"Datta SK, Kalled SL: CD40-CD40 ligand interaction in autoimmune disease. Arthritis Rheum 1997, 40:1735\u20131745.","journal-title":"Arthritis Rheum"},{"key":"30_CR49","doi-asserted-by":"crossref","first-page":"11310","DOI":"10.1074\/jbc.274.16.11310","volume":"274","author":"K Seyama","year":"1999","unstructured":"Seyama K, Osborne WR, Ochs HD: CD40 ligand mutants responsible for X-linked hyper-IgM syndrome associate with wild type CD40 ligand. J Biol Chem 1999, 274:11310\u201311320.","journal-title":"J Biol Chem"},{"key":"30_CR50","doi-asserted-by":"crossref","first-page":"33545","DOI":"10.1074\/jbc.274.47.33545","volume":"274","author":"E Garber","year":"1999","unstructured":"Garber E, Su L, Ehrenfels B, et al.: CD154 variants associated with hyper-IgM syndrome can form oligomers and trigger CD40-mediated signals. J Biol Chem 1999, 274:33545\u201333550.","journal-title":"J Biol Chem"}],"container-title":["Current Allergy and Asthma Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-001-0030-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11882-001-0030-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-001-0030-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T04:25:23Z","timestamp":1683865523000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11882-001-0030-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,9]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2001,9]]}},"alternative-id":["30"],"URL":"https:\/\/doi.org\/10.1007\/s11882-001-0030-6","relation":{},"ISSN":["1529-7322","1534-6315"],"issn-type":[{"value":"1529-7322","type":"print"},{"value":"1534-6315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,9]]}}}